The effect of evidence-based, treatment-oriented, clinical practice guidelines on improving patient care outcomes

Colbeck, Marc; Lockwood, Craig; Peters, Micah D J; Fulbrook, Paul; McCabe, Delia

doi:10.11124/jbisrir-2016-002515

Cited by 4 publications

(4 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This again ties up with concerns with the lack of human resources and scarcity of expertise among surveyed facilities. Applying guidelines is an intervention to support clinical-decision making and enhance care [ 90 , 91 , 92 , 93 ]. It is however important to include the opinion of key personnel from medical specialties when developing policies and guidelines for prescribing, including antimicrobial prescribing, to enhance guideline acceptability and use [ 37 , 89 , 94 , 95 ].…”

Section: Discussionmentioning

confidence: 99%

Antimicrobial Stewardship Activities in Public Healthcare Facilities in South Africa: A Baseline for Future Direction

et al. 2021

View full text Add to dashboard Cite

Antimicrobial resistance (AMR) is a growing problem worldwide, including South Africa, where an AMR National Strategy Framework was implemented to instigate antimicrobial stewardship programmes (ASPs) and improve antimicrobial prescribing across sectors. To address the need to assess progress, a sequential mixed methodology with an explanatory research design was employed. In Phase 1, a self-administered questionnaire was completed by healthcare professionals (HCPs) from 26 public sector healthcare facilities across South Africa to assess compliance with the Framework. The results were explored in Phase 2 through 10 focus group discussions and two in-depth interviews, including 83 participants. Emerging themes indicated that public healthcare facilities across South Africa are facing many challenges, especially at entry level primary healthcare (PHC) facilities, where antimicrobial stewardship activities and ASPs are not yet fully implemented. Improved diagnostics and surveillance data are a major shortcoming at these facilities. Continuous education for HCPs is deficient, especially for the majority of prescribers at PHC level and health campaigns are nearly non-existent. Involvement and visibility of management at certain facilities is a serious shortfall. Consequently, it is important to call attention to the challenges faced with improving antimicrobial prescribing across countries and address these to reduce AMR, especially in PHC facilities, being the first point of access to healthcare for the vast majority of patients in developing countries.

show abstract

Section: Discussionmentioning

confidence: 99%

Antimicrobial Stewardship Activities in Public Healthcare Facilities in South Africa: A Baseline for Future Direction

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The results of our study point to the use of clinical guidelines as the most important key intervention to enhance RUM (Figure 1). Whilst clinical guidelines have been instrumental in optimizing care and promoting RUM across settings (Ament et al, 2015;Colbeck et al, 2016;Ebben et al, 2018;Brouwers et al, 2019;Niaz et al, 2019;Richards et al, 2019), there are challenges such as regularly updating the guidance or sufficient government or health authority funding for their development and active dissemination in the first place. There can also be concerns with conflicts of interest among guideline developers unless adequately addressed such as the "Wise List" and guidance in Stockholm, Sweden (Gustafsson et al, 2011;Bjorkhem-Bergman et al, 2013;Shnier et al, 2016;DeJong and Steinbrook, 2018;The Lancet, 2019).…”

Section: Discussionmentioning

confidence: 99%

Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions

Gad

Salem²,

Oortwijn

et al. 2020

Front. Pharmacol.

View full text Add to dashboard Cite

show abstract

“…This may be related to the wide variety of outcomes measured across individual studies, methodological heterogeneity, and differences in the patient populations being evaluated. 13,14 Clinical practice guidelines can serve as a bridge between the available evidence and its implementation into clinical practice, providing guidance on diagnostic and treatment options on the basis of efficacy, safety, and cost; this in turn increases the likelihood that patients will receive a consistent level of care, regardless of geographic location, clinician type, or medical specialty. 11,15,16 In addition, CPGs that are accompanied by educational tools for patients or caregivers and that are widely disseminated can empower patients to make more informed health care decisions and promote shared decision-making between patients and their providers.…”

Section: Benefits To Patientsmentioning

confidence: 99%

“…Although previous systematic reviews have reported significant improvements, the degree of improvement varies across studies. This may be related to the wide variety of outcomes measured across individual studies, methodological heterogeneity, and differences in the patient populations being evaluated 13,14 …”

Section: Rationale For Clinical Practice Guidelinesmentioning

confidence: 99%

Overview of clinical practice guideline development, application to pharmacy practice, and roles for pharmacists

Harris

Aljadeed

Anderson

et al. 2022

J Am Coll Clin Pharm

View full text Add to dashboard Cite

All health care professionals have a responsibility to integrate current evidence‐based medicine into their clinical practice to ensure the best possible patient care. Clinical practice guidelines (CPGs) play a major role in helping clinicians identify when and how to implement evidence into routine clinical practice to improve patient outcomes. The primary intent of CPGs is to benefit patients by improving the quality of care; however, CPGs also improve efficiency and effectiveness within the health care system. The process used to develop CPGs is important to ensure the recommendations are trustworthy, based on the highest‐quality evidence, and free of significant conflicts of interest. The National Academy of Medicine (NAM) published guidance on best practices for developing CPGs in 1990 and again in 2011. Additional guidance is provided by various reporting checklists for CPGs, such as the Appraisal of Guidelines for Research & Evaluation (AGREE) II and Reporting Items for Practice Guidelines in Healthcare (RIGHT) instruments. However, analyses of published CPGs show inconsistent application of these best practices. This paper discusses the benefits of CPGs, reviews the guideline development process, discusses limitations in this process and in applying CPGs to patient care, identifies opportunities for improvement, provides considerations for educating learners and other health care professionals about CPGs, and examines the role of pharmacists in CPG development, dissemination, and implementation.

show abstract

The effect of evidence-based, treatment-oriented, clinical practice guidelines on improving patient care outcomes

Abstract: The question that this systematic review aims to address is: does the use of evidence-based, treatment-oriented, clinical practice guidelines by healthcare professionals result in improvements in patient outcomes?

Cited by 4 publications

References 12 publications

Antimicrobial Stewardship Activities in Public Healthcare Facilities in South Africa: A Baseline for Future Direction

Antimicrobial Stewardship Activities in Public Healthcare Facilities in South Africa: A Baseline for Future Direction

Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions

Overview of clinical practice guideline development, application to pharmacy practice, and roles for pharmacists

Contact Info

Product

Resources

About